Gregor Werba
Impact in
- Oncology top 5%
- Pancreatic and Hepatic Oncology Research
- Cancer Immunotherapy and Biomarkers
- Cancer Cells and Metastasis
- Immunology top 10%
- Immune cells in cancer
- Immune Cell Function and Interaction
- Immunotherapy and Immune Responses
Papers in
- Oncology 15
- Pancreatic and Hepatic Oncology Research 11
- Cancer Immunotherapy and Biomarkers 4
-
- Immune Cell Function and Interaction 2
- Co-authors
- Cristina Hajdu (3 shared papers)George Miller (4 shared papers)Diane M. Simeone (5 shared papers)Mautin Hundeyin (3 shared papers)Donnele Daley (3 shared papers)Lena Seifert (3 shared papers)Rocky Barilla (3 shared papers)Vishnu R. Mani (3 shared papers)
- Journals
- Cancer Research (2 papers)PLoS ONE (2 papers)HPB (2 papers)Journal of the American College of Surgeons (1 paper)Gastroenterology (1 paper)
- Partner nations
- United StatesAustriaSwitzerland
In The Last Decade
Gregor Werba
26 papers receiving 1.2k citations
Gregor Werba's Hit Papers
Peers
Comparison fields: 5 of 80
- Oncology 519
- Immunology 389
- Cancer Research 159
- Genetics 61
- Molecular Biology 374
Countries citing papers authored by Gregor Werba
This map shows the geographic impact of Gregor Werba's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gregor Werba with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gregor Werba more than expected).
Fields of papers citing papers by Gregor Werba
This network shows the impact of papers produced by Gregor Werba. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gregor Werba. The network helps show where Gregor Werba may publish in the future.
Co-authors
The 25 scholars most cited alongside Gregor Werba, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 260 | |
| 2 | Cancer cell states recur across tumor types and form specific interactions with the tumor microenvironment Hit paper breakdown → | 2022 | 259 |
| 3 | 2016 | 155 | |
| 4 | 2020 | 115 | |
| 5 | 2021 | 89 | |
| 6 | 2011 | 62 | |
| 7 | 2013 | 54 | |
| 8 | 2023 | 42 | |
| 9 | 2013 | 25 | |
| 10 | 2021 | 18 | |
| 11 | 2019 | 18 | |
| 12 | A phase II trial of two durations of Bevacizumab added to neoadjuvant gemcitabine for borderline and locally advanced pancreatic cancer. | 2014 | 17 |
| 13 | 2012 | 15 | |
| 14 | 2018 | 11 | |
| 15 | 2021 | 10 | |
| 16 | 2021 | 8 | |
| 17 | 2021 | 7 | |
| 18 | 2013 | 5 | |
| 19 | 2022 | 4 | |
| 20 | 2016 | 4 |
About Gregor Werba
Gregor Werba is a scholar working on Oncology, Immunology, Molecular Biology, Surgery and Cardiology and Cardiovascular Medicine, having authored 27 papers that have together received 1.2k indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (11 papers), Cancer Immunotherapy and Biomarkers (4 papers), Cardiac Fibrosis and Remodeling (3 papers), Cancer Genomics and Diagnostics (2 papers), Immune Cell Function and Interaction (2 papers), Epigenetics and DNA Methylation (2 papers), Cancer Research and Treatments (2 papers) and Mesenchymal stem cell research (2 papers). The work is most often cited by research in Oncology (519 citations), Immunology (389 citations), Cancer Research (159 citations), Genetics (61 citations) and Molecular Biology (374 citations). Gregor Werba has collaborated with scholars based in United States, Austria and Switzerland. Frequent co-authors include Cristina Hajdu, George Miller, Diane M. Simeone, Mautin Hundeyin, Donnele Daley, Lena Seifert, Rocky Barilla, Vishnu R. Mani, Costas A. Lyssiotis and Gregory L. Beatty. Their work appears in journals such as Cancer Research, PLoS ONE, HPB, Journal of the American College of Surgeons and Gastroenterology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.